Popular Stories


  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Otonomy Enters Strategic Collaboration with AGTC to develop a novel Gene Therapy for Congenital Hearing Loss

Otonomy Inc (NASDAQ: OTIC), a biopharmaceutical company focussed on providing neurotology solutions, announced a strategic collaboration with Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, to create, develop and commercialize an AAV-based...

Emerging Gene Therapy comes to the aid of hearing loss patients

Hearing impairment is a chronic disability that affects people of all age groups. Worldwide over 360 million people are affected by this condition making it the second most prevalent health issue. According to the data made available by National Institute on Deafness and Other Communication Disorders (NIDCD),...

WordPress Video Lightbox Plugin